Tafinlar's Potential Side Effects: Frequent, Mild to Severe
Tafinlar, a kinase inhibitor available in oral capsule form, is a brand-name prescription medication used to treat several types of cancer, including melanoma, anaplastic thyroid cancer, non-small cell lung cancer, and solid tumors in adults and children aged 6 years and older.
However, like many medications, Tafinlar comes with potential side effects. For instance, if you have diabetes or high blood sugar, taking Tafinlar may exacerbate your condition, and your doctor may recommend closer monitoring of your blood sugar levels.
One common side effect of Tafinlar, especially when combined with another medication called Mekinist, is a rash. Other common side effects include fever, fatigue, nausea, diarrhea, skin dryness, and eye irritation. These side effects are more prevalent in patients treated with Tafinlar plus Mekinist for cancers with specific BRAF mutations.
Eye problems can be significant and may include inflammation, redness, dry eye, blurred vision, and itching. If you experience any of these symptoms while taking Tafinlar, it's essential to speak with your doctor immediately. They can examine your eyes and treat uveitis as soon as possible.
During Tafinlar treatment, if you develop a fever, your doctor may recommend taking medication to reduce your fever, such as acetaminophen, and may have you monitor your temperature. If your fever is above 104°F or you develop a serious febrile reaction, your doctor will likely pause your Tafinlar treatment. In some cases, they may prescribe a steroid medication, such as prednisone.
It's important to note that Tafinlar must be BRAF-positive, meaning the cancer cells have specific gene mutations. If you have a bleeding problem, such as hemophilia, you may be at an increased risk of bleeding during your Tafinlar treatment. Your doctor may monitor you more often than usual for symptoms of bleeding.
Serious side effects of Tafinlar may include new cancer, serious skin-related side effects, heart problems, hyperglycemia, eye and vision problems, serious febrile reaction, bleeding, severe allergic reaction, and side effects in children.
If you have a heart problem, such as congestive heart failure, tell your doctor before taking Tafinlar. People with heart problems weren't included in clinical trials of Tafinlar, so it's not known what effects the drug may have on people with these problems.
If you have liver problems, tell your doctor before starting treatment with Tafinlar. The medication wasn't studied in people with moderate to severe liver problems, so it's not known how people with these problems may respond to treatment.
Tafinlar may be taken as a long-term treatment or for 1 year as adjuvant therapy for melanoma. It's worth noting that Tafinlar and Mekinist are not chemotherapy drugs and likely cause fewer side effects than chemotherapy.
In summary, while Tafinlar offers a new treatment option for certain types of cancer, it's crucial to be aware of its potential side effects. Regular communication with your doctor about any symptoms you experience is essential for safe and effective treatment.
- Tafinlar, a medication used for treating lung cancer, melanoma, and other types of cancer, can potentially exacerbate diabetes or high blood sugar, requiring closer monitoring of blood sugar levels by medical professionals.
- Combining Tafinlar with another drug called Mekinist may lead to a common side effect of rash, as well as fever, fatigue, nausea, diarrhea, skin dryness, eye irritation, and eye problems such as inflammation and blurred vision.
- If you have a heart problem, such as congestive heart failure, or a bleeding disorder like hemophilia, you should disclose this information to your doctor before starting Tafinlar treatment, as the drug's effects on these medical conditions are not fully understood.
- Tafinlar may cause serious side effects, including new cancer, skin-related issues, heart problems, hyperglycemia, eye and vision problems, febrile reaction, bleeding, severe allergic reactions, and side effects in children.
- It's essential to communicate consistently with your doctor about any symptoms or concerns that arise during Tafinlar treatment, as this will ensure safe and effective medical care in the context of health-and-wellness and oncology.
